Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma

  1. Salles, G.
  2. Schuster, S.J.
  3. Dreyling, M.
  4. Fischer, L.
  5. Kuruvilla, J.
  6. Patten, P.E.M.
  7. von Tresckow, B.
  8. Smith, S.M.
  9. Jiménez-Ubieto, A.
  10. Davis, K.L.
  11. Anjos, C.
  12. Chu, J.
  13. Zhang, J.
  14. Bodoni, C.L.
  15. Thieblemont, C.
  16. Fowler, N.H.
  17. Dickinson, M.
  18. Martínez-López, J.
  19. Wang, Y.
  20. Link, B.K.
Aldizkaria:
Blood Advances

ISSN: 2473-9537,  2473-9529

Argitalpen urtea: 2022

Alea: 6

Zenbakia: 22

Orrialdeak: 5835-5843

Mota: Artikulua

DOI: 10.1182/BLOODADVANCES.2022008150 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus